News

FDA chief talks staffing, abortion drug and tobacco
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
STAT18d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
CBO finds health agency cuts would result in fewer new drugs
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis.
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...
Dermatology Advisor2d
Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision
Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...
Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
HealthLeaders Media17d
FDA Layoffs Could Compromise Safety of Medications Made at Foreign ...
Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.